Aquilo Capital Management, LLC has disclosed 12 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2018-09-30. The current portfolio value is calculated to be $239.00 Mil. The turnover rate is 13%.
In Aquilo Capital Management, LLC's current portfolio as of 2018-09-30, the top 5 holdings are
Merus NV (MRUS), Merus NV (MRUS), Loxo Oncology Inc (LOXO), Loxo Oncology Inc (LOXO), Fate Therapeutics Inc (FATE), not including call and put options.
Aquilo Capital Management, LLC did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Aquilo Capital Management, LLC, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Aquilo Capital Management, LLC, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Aquilo Capital Management, LLC.